Biosynth (Peptide Division), formerly vivitde and Pepscan is showcasing its offering across the full range of peptide products and services. From custom peptide synthesis and library production, lead discovery and optimization, large scale peptide manufacture and GMP compliant NCEs, neoantigen peptides.
We are experienced in targeted nuclear medicine, both in diagnostic imaging and therapy as well as theranostics. Peptides play an important role in this field as they can specifically deliver both radioactive markers and therapies to a tumor.
Biosynth offers a unique CLIPS™ phage display platform to discover highly constrained de novo peptides with enhanced affinity against your target of interest, selectivity, and proteolytic stability. Come and talk to the Biosynth team if you want to know how we can assist you in progressing your peptide project through (pre-) clinical development, application, and commercialization.
Securing Life Sciences Supply Chains. www.biosynth.com